focus
Previous article:
DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article: Readout Newsletter: The latest on Novavax, Merck, Bluebird
Next article: Readout Newsletter: The latest on Novavax, Merck, Bluebird
Wikipedia
knowledge
-
Investment in vaccine development is lagging, report finds
2025-09-30 23:56 -
Readout Newsletter: The latest on Novavax, Merck, Bluebird
2025-09-30 23:50 -
Contact tracing may help avoid another lockdown. Can it work in the U.S.?
2025-09-30 22:50 -
Court strikes down limits on filming of police in Arizona
2025-09-30 22:31 -
White House launches permanent pandemic office
2025-09-30 22:21 -
Biogen walks away from Aduhelm, years after polarizing approval
2025-09-30 22:13